Skip to main content
OpenTrials

Clinical trial condition

Plasma Cell Myeloma

Explore clinical trials studying Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.

79 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Plasma Cell Myeloma trial results

Active, Not Recruiting

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

NCT05669989

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Washington University- Site Number : 8400001 St Louis, Missouri, United States
  • Investigational Site Number : 0360006 Blacktown, New South Wales, Australia
  • Investigational Site Number : 0360001 Saint Leonards, New South Wales, Australia
  • Investigational Site Number : 0360003 Wollongong, New South Wales, Australia
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

NCT03319667

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Investigational Site Number: 8400006 Fort Myers, Florida, United States
  • Investigational Site Number: 8400004 St. Petersburg, Florida, United States
  • Investigational Site Number: 8400007 Kansas City, Missouri, United States
  • Investigational Site Number: 8400005 Nashville, Tennessee, United States
View all 104 locations
View Trial Details
Active, Not Recruiting

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

NCT04977024

Conditions
Blood Protein Disorders, COVID-19, COVID-19 Infection, +30 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • U Mass Chan Medical School Worcester, Massachusetts, United States
  • SUNY-Stony Brook Stony Brook, New York, United States
View Trial Details

Related conditions